Israel-based Teva Pharmaceutical Industries is expected to name Anglo-Swedish group AstraZeneca's Chief Executive Pascal Soriot as Teva's next CEO, Reuters reported on Wednesday, citing the Israeli Calcalist financial news website.
Soriot has met with Teva's search committee and its chairman and expressed his agreement to serve as its next CEO, Calcalist said.
Read more